Browsing Tag
pharma
NZ’s new disclosure scheme for pharma payments to doctors falls short of best practice
Pharmaceutical industry payments to doctors are common, often substantial and can affect clinical decision making.
Seven years after the industry trade association Medicines New Zealand first mooted a disclosure system,…
LEO Pharma Unveils Late-Breaking Data for Landmark DELTA 3 Open-Label Extension Trial at the 2024…
MADISON, N.J.--(BUSINESS WIRE)--LEO Pharma Unveils Late-Breaking Data for Landmark DELTA 3 Open-Label Extension Trial at the 2024 AAD Annual Meeting
Samenvatting: GENESIS Pharma kondigt een exclusieve distributieovereenkomst aan met Regeneron…
ATHENS, Griekenland--(BUSINESS WIRE)--GENESIS Pharma, een regionaal biofarmaceutisch bedrijf gespecialiseerd in het op de markt brengen van innovatieve geneesmiddelen voor ernstige en zeldzame ziekten in Centraal- en Oost-Europa, kondigt…
Riassunto: GENESIS Pharma annuncia un accordo di distribuzione esclusiva con Regeneron…
ATENE, Grecia--(BUSINESS WIRE)--GENESIS Pharma, azienda biofarmaceutica regionale specializzata nella commercializzazione di farmaci innovativi per il trattamento di malattie gravi e rare nell'Europa centrale e orientale, ha annunciato…
GENESIS Pharma Announces an Exclusive Distribution Agreement With Regeneron Pharmaceuticals to…
ATHENS, Greece--(BUSINESS WIRE)--GENESIS Pharma announces an exclusive distribution agreement with Regeneron Pharmaceuticals to commercialize cemiplimab in Greece, Cyprus and Malta.
IGC Pharma Reports Third Quarter Fiscal 2024 Results
POTOMAC, Md.--(BUSINESS WIRE)-- #AD--IGC Pharma Reports Third Quarter Fiscal 2024 Results
Warren, Jayapal Announce Three Drug Manufacturers Pulled Sham Patents after Warnings, Urge FDA to…
February 16, 2024
Lawmakers Probed Big Pharma’s Sham Patent Claims after FTC Warnings in December 2023; Are Now Sharing Responses with FDA to Assist in Development of New Orange Book Guidance
Text of Letter…
Delta-Fly Pharma Inc. : avis de lancement d’un essai clinique comparatif pivot de phase III sur le…
TOKUSHIMA, Japon--(BUSINESS WIRE)--Nous sommes ravis de partager nos dernières avancées en matière de développement. Comme présenté à la réunion annuelle 2022 de l’ASCO le 6 juin 2022, le DFP-14323, en combinaison avec l’afatinib (20…
Delta-Fly Pharma Inc.: Bekanntmachung des Beginns einer klinischen Phase-III-Vergleichsstudie mit…
TOKUSHIMA, Japan--(BUSINESS WIRE)--Wir freuen uns, Ihnen unseren neuesten Entwicklungsstand mitteilen zu können. DFP-14323 wurde auf der Jahrestagung 2022 der ASCO am 6. Juni 2022 vorgestellt und hat in Kombination mit Afatinib (20…
Delta-Fly Pharma Inc.: Notice of Initiation of Phase III Pivotal comparative clinical trial of…
TOKUSHIMA, Japan--(BUSINESS WIRE)--We are excited to share our latest development status. As presented at 2022 ASCO Annual Meeting on June 6, 2022, DFP-14323 in combination with afatinib (20 mg/day) in stage III/IV non-small cell lung…
Riassunto: Delta-Fly Pharma Inc.: aggiornamento sullo stato delle analisi ad interim dello studio di…
TOKUSHIMA, Giappone--(BUSINESS WIRE)--In seguito alle informazioni precedentemente diffuse il 5 gennaio 2024, siamo entusiasti di condividere la nostra più recente situazione di sviluppo. Di seguito è riportato lo stato attuale…
Riassunto: Delta-Fly Pharma Inc.: aggiornamento sulla fase di R&S di DFP-10917 e DFP-14927,…
TOKUSHIMA, Giappone--(BUSINESS WIRE)--A seguito delle precedenti informazioni del 30 giugno 2023, siamo entusiasti di condividere il nostra ultima fase di sviluppo. Uno studio clinico di fase III su DFP-10917 in pazienti affetti da…
Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board
SOMERVILLE, Mass.--(BUSINESS WIRE)-- #RNA--Sail Biomedicines Appoints Tech and Pharma Industry Veteran Frank D’Amelio to Its Board
Cancer Support Community Announces Founders Award for Innovation Honoree
WASHINGTON, D.C., May 13, 2022 (GLOBE NEWSWIRE) -- The Cancer Support Community (CSC) has announced that the Janssen Pharmaceutical Companies of Johnson & Johnson will be the recipient of the 2022 Founders Award for Innovation.…
Pharma Company Ferrer Certified B Corp for Its Positive Impact in Society
Ferrer has achieved a score of 100.6 points and is among only 25% of B Corps worldwide that have exceeded 100 points.
BARCELONA, Spain, January 26, 2022 (Newswire.com)
-
Ferrer, the…